A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents With Major Depression, Behavior Problems, and Substance Use Disorders
Overview
This randomized controlled trial evaluates the effects of fluoxetine versus placebo, combined with cognitive behavioral therapy, on adolescents diagnosed with major depression, conduct disorder, and substance use disorders. The study reports that the fluoxetine group showed greater improvement on one specific depression measure compared to the placebo group, though no significant differences were found for substance use or conduct disorder symptoms. This resource is primarily intended for clinicians and researchers interested in pharmacological interventions for comorbid adolescent psychiatric conditions.
- ID
f6c35044cffc4f83- Source org
- OpenAlex
- Author
- Paula Riggs (University of Colorado Health), Susan K. Mikulich‐Gilbertson (University of Colorado Health), Robert D. M. Davies (University of Colorado Health), Michelle Lohman (University of Colorado Health), Constance Klein (University of Colorado Health), Shannon K. Stover (University of Colorado Health)
- Published
- 2007-11-01
- OA status
- bronze
- DOI
- 10.1001/archpedi.161.11.1026
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 151
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkblocked via http-check · 2026-07-28T05:51:39.503185+00:00
Cite this entry
BibTeX
@article{allodium:f6c35044cffc4f83,
title = {A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents With Major Depression, Behavior Problems, and Substance Use Disorders},
author = {Paula Riggs and Susan K. Mikulich‐Gilbertson and Robert D. M. Davies and Michelle Lohman and Constance Klein and Shannon K. Stover},
year = {2007},
journal = {OpenAlex},
doi = {10.1001/archpedi.161.11.1026},
url = {https://doi.org/10.1001/archpedi.161.11.1026}
}RIS
TY - JOUR TI - A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents With Major Depression, Behavior Problems, and Substance Use Disorders AU - Riggs, Paula AU - Mikulich‐Gilbertson, Susan K. AU - Davies, Robert D. M. AU - Lohman, Michelle AU - Klein, Constance AU - Stover, Shannon K. PY - 2007 PB - OpenAlex DO - 10.1001/archpedi.161.11.1026 UR - https://doi.org/10.1001/archpedi.161.11.1026 ER -
APA
Riggs, P., Mikulich‐Gilbertson, S. K., Davies, R. D. M., Lohman, M., Klein, C., & Stover, S. K. (2007). A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents With Major Depression, Behavior Problems, and Substance Use Disorders. OpenAlex. https://doi.org/10.1001/archpedi.161.11.1026
Related entries
- Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression
- Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders
- On the learning curve: the emerging evidence supporting cognitive–behavioral therapies for adolescent substance abuse
- Cognitive Behavioral Therapy and Fluoxetine as Adjuncts to Group Behavioral Therapy for Binge Eating Disorder
- Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
- A Randomized Clinical Trial Comparing Individual Cognitive Behavioral Therapy and Child-Centered Therapy for Child Anxiety Disorders
- Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
- Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patients
- Long-term effectiveness of cognitive behavioral therapy (CBT) for children and adolescents in routine care
- Long-term effectiveness of cognitive behavioral therapy for youth with anxiety disorders